GlassScriptPhysician profile
Whitney L Chouteau
NPI 1639373129
$14,694.11
in general payments reported to CMS, 2019-2025
55 companies · $2,612 in 2025
The $2,612 reported for 2025 was more than what 83% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,698 · 2020: $957 · 2021: $1,856 · 2022: $2,275 · 2023: $2,266 · 2024: $3,030 · 2025: $2,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,373 · Travel and Lodging: $514 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,372.64 |
| Travel and Lodging | $514.13 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $2,381.13 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $1,617.68 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Forte Bio-Pharma LLC | $1,343.59 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,131.37 | 2019-2025 | Relistor |
| Medtronic, INC. | $807.96 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Medtronic USA, INC. | $772.38 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $670.03 | 2019-2025 | Ztlido |
| Spr Therapeutics, INC | $627.52 | 2023-2024 | Sprint Pns System |
| Pfizer INC. | $589.73 | 2019-2025 | |
| Allergan, INC. | $405.32 | 2019-2022 | |
| Abbott Laboratories | $386.83 | 2020-2025 | Eterna, Proclaim |
| Nevro Corp. | $371.16 | 2021-2024 | Senza |
| Ibsa Pharma INC. | $207.09 | 2021-2024 | Licart, Tirosint, Tirosint |
| Vertex Pharmaceuticals Incorporated | $202.08 | 2025 | |
| Merck Sharp & Dohme LLC | $190.27 | 2022-2023 | Belsomra, Verquvo |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $186.24 | 2025 | Roxybond |
| Lilly USA, LLC | $184.28 | 2021-2024 | Emgality, Reyvow |
| Azurity Pharmaceuticals, INC. | $174.21 | 2023-2025 | Horizant, Horizant |
| Almatica Pharma LLC | $143.58 | 2021-2022 | |
| Zynex Medical, INC. | $137.54 | 2023 | Nexwave |
| Bioventus LLC | $127.33 | 2020-2025 | Durolane, Gelsyn-3 |
| Valinor Pharma, LLC | $125.08 | 2023-2025 | Movantik |
| Pacira Therapeutics, INC. | $124.01 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $118.01 | 2019-2022 | |
| Redhill Biopharma INC. | $117.87 | 2020-2022 | |
| Horizon Therapeutics Plc | $117.39 | 2019-2022 | |
| Lundbeck LLC | $114.71 | 2022-2025 | Vyepti |
| Vertos Medical, INC. | $104.72 | 2022 | |
| Hikma Pharmaceuticals USA | $97.36 | 2022-2024 | Kloxxado |
| Nalu Medical, INC. | $89.02 | 2025 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $74.26 | 2021-2022 | |
| Daiichi Sankyo INC. | $72.05 | 2019 | |
| Fidia Pharma USA INC. | $70.87 | 2021-2025 | Triluron, Hymovis, Hyalgan |
| Si-Bone, INC. | $67.68 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.62 | 2022 | |
| Averitas Pharma INC. | $57.05 | 2023-2025 | Qutenza |
| Brainsway USA INC | $53.57 | 2022 | |
| Stryker Corporation | $52.93 | 2025 | Avs Pl |
| Boston Scientific Corporation | $52.22 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $51.33 | 2019-2023 | Iovera, Exparel, Zilretta |
| Axsome Therapeutics, INC. | $48.77 | 2025 | Symbravo |
| Baudax Bio INC. | $47.90 | 2021 | |
| Biodelivery Sciences International, INC. | $37.12 | 2020-2021 | |
| Depuy Synthes Sales INC. | $36.95 | 2024-2025 | Orthovisc, Monovisc |
| Kowa Pharmaceuticals America, INC. | $30.53 | 2022-2023 | Seglentis |
| Uswm, LLC | $28.72 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.17 | 2019 | |
| Biotronik Nro, INC. | $25.59 | 2025 | Prospera |
| Globus Medical, INC. | $21.57 | 2025 | Senza |
| Tonix Medicines, INC. | $21.05 | 2025 | Tonmya |
| Radius Health, INC. | $20.52 | 2019 | |
| Idorsia Pharmaceuticals US INC | $20.03 | 2025 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $18.96 | 2021 | |
| Pernix Therapeutics Holdings, INC. | $15.16 | 2019 | |
| Saluda Medical Americas, INC. | $11.00 | 2025 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Chouteau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.